Finemark National Bank & Trust Decreased Its Stake in Cme Group INC (CME) by $5.30 Million as Stock Value Declined

March 18, 2018 - By Linda Rogers

Investors sentiment decreased to 1.01 in Q3 2017. Its down 0.12, from 1.13 in 2017Q2. It dropped, as 53 investors sold CME shares while 219 reduced holdings. 56 funds opened positions while 220 raised stakes. 265.89 million shares or 1.13% less from 268.92 million shares in 2017Q2 were reported. Edgewood Management Ltd Liability Company, New York-based fund reported 7.68 million shares. First Midwest Bancorp Division has 0.26% invested in CME Group Inc. (NASDAQ:CME) for 15,441 shares. Laurion Cap Mgmt Limited Partnership has 0.02% invested in CME Group Inc. (NASDAQ:CME) for 33,775 shares. First Allied Advisory Serv has invested 0.02% in CME Group Inc. (NASDAQ:CME). Bp Public Limited Company has invested 0.47% of its portfolio in CME Group Inc. (NASDAQ:CME). Invesco Limited stated it has 923,777 shares or 0.05% of all its holdings. Skylands Ltd Liability Company has 0.42% invested in CME Group Inc. (NASDAQ:CME) for 23,200 shares. 3,016 were reported by Summit Asset Lc. Oz Ltd Partnership owns 30,000 shares for 0.02% of their portfolio. Zurcher Kantonalbank (Zurich Cantonalbank) reported 0.09% in CME Group Inc. (NASDAQ:CME). Pension Serv has 290,782 shares. Horan Cap Advsr Limited Liability Corporation has invested 0.03% of its portfolio in CME Group Inc. (NASDAQ:CME). Envestnet Asset Incorporated invested 0% of its portfolio in CME Group Inc. (NASDAQ:CME). Aviva Public Ltd, United Kingdom-based fund reported 210,577 shares. Investec Asset Mngmt Ltd has 645,375 shares for 0.38% of their portfolio.

Since October 5, 2017, it had 0 buys, and 11 sales for $9.81 million activity. On Wednesday, October 11 Pietrowicz John W. sold $342,075 worth of CME Group Inc. (NASDAQ:CME) or 2,500 shares. DUFFY TERRENCE A sold $3.03M worth of stock. Tobin Jack J had sold 2,325 shares worth $354,051 on Monday, December 18. On Wednesday, February 14 the insider Pankau Ronald A. sold $31,982. Another trade for 1,350 shares valued at $186,300 was sold by Piell Hilda Harris. Kometer Kevin sold $2.61M worth of stock.

Finemark National Bank & Trust decreased its stake in Cme Group Inc (CME) by 46.43% based on its latest 2017Q3 regulatory filing with the SEC. Finemark National Bank & Trust sold 39,281 shares as the company’s stock declined 4.72% while stock markets rallied. The institutional investor held 45,317 shares of the investment bankers and brokers and service company at the end of 2017Q3, valued at $6.15M, down from 84,598 at the end of the previous reported quarter. Finemark National Bank & Trust who had been investing in Cme Group Inc for a number of months, seems to be less bullish one the $ market cap company. It closed at $0 lastly. It is down 25.35% since March 18, 2017 and is uptrending. It has outperformed by 8.65% the S&P500.

Finemark National Bank & Trust, which manages about $1.50B US Long portfolio, upped its stake in Texas Instrs Inc (NASDAQ:TXN) by 36,723 shares to 49,842 shares, valued at $4.47 million in 2017Q3, according to the filing.

Analysts await CME Group Inc. (NASDAQ:CME) to report earnings on April, 26. They expect $1.64 EPS, up 34.43 % or $0.42 from last year’s $1.22 per share. After $1.12 actual EPS reported by CME Group Inc. for the previous quarter, Wall Street now forecasts 46.43 % EPS growth.

CME Group Inc. (NASDAQ:CME) Ratings Coverage

Among 18 analysts covering CME Group (NASDAQ:CME), 10 have Buy rating, 1 Sell and 7 Hold. Therefore 56% are positive. CME Group has $187.0 highest and $2.78 lowest target. $131.10’s average target is 0.00% above currents $0 stock price. CME Group had 61 analyst reports since August 3, 2015 according to SRatingsIntel. The stock has “Buy” rating by Bank of America on Thursday, March 8. The firm has “Buy” rating given on Friday, February 2 by Bank of America. The company was maintained on Monday, July 10 by Jefferies. The stock of CME Group Inc. (NASDAQ:CME) has “Neutral” rating given on Monday, November 14 by JP Morgan. The firm has “Hold” rating given on Friday, February 2 by Keefe Bruyette & Woods. The firm earned “Overweight” rating on Tuesday, October 10 by Barclays Capital. The rating was maintained by RBC Capital Markets on Monday, February 8 with “Underperform”. The rating was maintained by Jefferies with “Buy” on Wednesday, September 27. Keefe Bruyette & Woods maintained CME Group Inc. (NASDAQ:CME) on Wednesday, July 5 with “Hold” rating. On Tuesday, October 10 the stock rating was maintained by Keefe Bruyette & Woods with “Hold”.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.